Major Projects
Funds ambitious research projects advancing dementia treatment, diagnosis, or prevention, supporting innovative clinical and translational science but excluding clinical trials and drug discovery.
Funder: Alzheimer's Research UK
Due Dates: Applications open July 2026 | Deadline TBC October 2026
Funding Amounts: Up to £750,000; flexible funding for up to five years; minimum £50,000; no indirect costs covered.
Summary: Supports ambitious, high-impact research projects advancing treatment, diagnosis, or prevention of dementia, including innovative sub-studies.
Key Information: Lead applicant must be UK-based; clinical trials and drug discovery are not eligible under this scheme.
Description
This scheme funds intermediate to large-scale research projects that align with Alzheimer’s Research UK’s strategy, focusing on the treatment, diagnosis, and prevention of dementia. The grant encourages bold, ambitious, and high-impact ideas, particularly in clinical and translational research, aiming to accelerate progress toward a cure. The scheme also supports "added value" sub-studies of existing or planned clinical trials, such as validating new biomarkers or digital outcome measures. Funding is flexible to accommodate the scientific needs and nature of the research, and proposals should be driven by scientific opportunity. The scheme is not intended for clinical trials or for drug discovery/development, which are supported by other ARUK programs.
